Bibliography Bird SM. Slower decline of plasma HIV-1 RNA after highly active antiretroviral therapy in primary versus chronic infection. AIDS 2001 May 25:15(8):1087. ** Kane B. Should we treat acute HIV infection? Annals of Int Med. 2001 May 15;134(10):1011-1013. Berrey MM, Schacker T, Collier AC, Shea T, Brodie SJ, Mayers D, Coombs R, Krieger J, Chun T-W, Fauci A, Self SG, Core L. Treatment of primary Human Immunodeficiency Virus type 1 infection with potent antiretroviral therapy reduces frequencey of rapid progression to AIDS. J of Infect Dis 2001 May 15; 183:1466-1475. Pilcher CD, Shugars DC, Fiscus SA, Miller WC, Menezes P, Giner J, Dean B, Robertson K, Hart CE, Lennox JL, Eron JJ Jr, Hicks CB. HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS 2001 May 4; 15(7):837-45. Benson CA.Structured treatment interruption in HIV infection. AIDS Read. 2001 Feb;11(2):99-102. ** Altfeld M, Rosenberg ES, Shankarappa R, Mukherjee JS, Hecht FM, Eldridge RL, Addo MM, Poon SH, Phillips MN, Robbins GK, Sax PE, Boswell S, Kahn JO, Brander C, Goulder PJ, Levy JA, Mullins JI, Walker BD. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med. 2001 Jan 15;193(2):169-80. Vergis EN, Mellors JW. Natural history of HIV-1 infection. Infect Dis Clin North Am. 2000 Dec;14(4):809-25, v-vi. Review. ** Rosenberg ES, Altfeld M, Poon SH, Phillips MN, Wilkes BM, Eldridge RL, Robbins GK, D'Aquila RT, Goulder PJ, Walker BD. Immune control of HIV-1 after early treatment of acute infection. Nature. 2000 Sep 28;407(6803):523-6. Wodarz D, Arnaout RA, Nowak MA, Lifson JD. Transient antiretroviral treatment during acute simian immunodeficiency virus infection facilitates long-term control of the virus. Philos Trans R Soc Lond B Biol Sci. 2000 Aug 29;355(1400):1021-9. Review. McMichael AJ, Callan M, Appay V, Hanke T, Ogg G, Rowland-Jones S. The dynamics of the cellular immune response to HIV infection: implications for vaccination. Philos Trans R Soc Lond B Biol Sci. 2000 Aug 29;355(1400):1007-11. Review. Wilson JD, Ogg GS, Allen RL, Davis C, Shaunak S, Downie J, Dyer W, Workman C, Sullivan S, McMichael AJ, Rowland-Jones SL. Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection. AIDS. 2000 Feb 18;14(3):225-33. Little SJ, McLean AR, Spina CA, Richman DD, Havlir DV. Viral dynamics of acute HIV-1 infection. J Exp Med. 1999 Sep 20;190(6):841-50. Thornton CW, Corbett C, Brown R. HIV infection in adults: a therapeutic update. Am J Manag Care. 1999 Aug;5(8):1047-60; quiz 1061-3. Markowitz M, Vesanen M, Tenner-Racz K, Cao Y, Binley JM, Talal A, Hurley A,Jin X, Chaudhry MR, Yaman M, Frankel S, Heath-Chiozzi M, Leonard JM, Moore JP,Racz P, Nixon DF, Ho DD, J X. The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses. J Infect Dis. 1999 Mar;179(3):527-37. ** Vanhems P, Lecomte C, Fabry J. Primary HIV-1 infection: diagnosis and prognostic impact. AIDS Patient Care STDS. 1998 Oct;12(10):751-8. Review. Riggs NL, Little SJ, Richman DD, Guatelli JC. Cell-associated viral RNA expression during acute infection with HIV type 1. AIDS Res Hum Retroviruses. 1998 Sep 1;14(13):1141- Iribarren JA, Miralles P, Baraia J, Diez F. [Anti-retroviral treatment. Treatment in special situations: acute infection, pregnancy, central nervous system involvement, thrombocytopenia, accidental exposure]. Enferm Infecc Microbiol Clin. 1996 Oct;14 Suppl 1:36-43. Review. Spanish. Phillips AN. Reduction of HIV concentration during acute infection: independence from a specific immune response. Science. 1996 Jan 26;271(5248):497-9. Kinloch-de Loes S, de Saussure P, Saurat JH, Stalder H, Hirschel B, Perrin LH. Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31 cases. Clin Infect Dis. 1993 Jul;17(1):59-65. |